You have 9 free searches left this month | for more free features.

Fedratinib

Showing 1 - 22 of 22

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Real World Evidence of Fedratinib Effectiveness in MF

Not yet recruiting
  • Primary Myelofibrosis
  • +2 more
  • Fedratinib
  • (no location specified)
May 22, 2023

Assess the Safety of Fedratinib in Korean Myelofibrosis

Recruiting
  • Primary Myelofibrosis
  • +2 more
  • Fedratinib
  • Seoul, Korea, Republic of
    Bristol-Myers Squibb YH
Oct 3, 2023

Myeloproliferative Tumor Trial in Tampa (Fedratinib Pill)

Recruiting
  • Myeloproliferative Neoplasm
  • Fedratinib Pill
  • Tampa, Florida
    Moffitt Cancer Center
Nov 28, 2022

Assess Real-World Patient-Reported Outcomes With Fedratinib for

Recruiting
  • Myelofibrosis
    • City, State, Austria
      Local Institution
    Dec 16, 2022

    Primary Myelofibrosis, Secondary Myelofibrosis Trial in Greifswald, Halle (Saale) (Fedratinib Oral Capsule [Inrebic], Nivolumab)

    Recruiting
    • Primary Myelofibrosis
    • Secondary Myelofibrosis
    • Greifswald, Germany
    • +1 more
    Jun 15, 2022

    Myeloproliferative Tumor, Chronic Neutrophilic Leukemia, MDS Trial in Tampa (Fedratinib Pill)

    Recruiting
    • Myeloproliferative Neoplasm
    • +2 more
    • Fedratinib Pill
    • Tampa, Florida
      Moffitt Cancer Center
    Jun 15, 2022

    IDH Mutation, IDH1 Mutation, IDH2 Gene Mutation Trial in Chicago (Ivosidenib, Enasidenib, Fedratinib)

    Recruiting
    • IDH Mutation
    • +4 more
    • Chicago, Illinois
      University of Chicago Medical Center
    Nov 12, 2021

    Healthy Volunteers Trial in Austin (Fedratinib, Fluconazole)

    Completed
    • Healthy Volunteers
    • Austin, Texas
      PPD Phase 1 Clinic
    Nov 17, 2021

    Acute Myeloid Leukemia, Essential Thrombocythemia, Myelodysplastic Syndrome Trial in Seattle (Decitabine, Ruxolitinib,

    Recruiting
    • Acute Myeloid Leukemia
    • +8 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Aug 18, 2022

    Myelofibrosis Trial in Worldwide (BMS-986158, Ruxolitinib, Fedratinib)

    Recruiting
    • Myelofibrosis
    • La Jolla, California
    • +36 more
    Jan 13, 2023

    Primary Myelofibrosis Trial in Japan (Fedratinib)

    Recruiting
    • Primary Myelofibrosis
    • Fedratinib
    • Suwa, Nagano, Japan
    • +25 more
    Jan 18, 2023

    Myelofibrosis, Polycythemia Vera, Thrombocythemia Trial in Worldwide (itacitinib)

    Active, not recruiting
    • Myelofibrosis
    • +2 more
    • New Orleans, Louisiana
    • +20 more
    Aug 25, 2022

    Myelofibrosis Trial in Summit (Oral Fedratinib)

    Available
    • Myelofibrosis
    • Oral Fedratinib
    • Summit, New Jersey
      Celgene
    Sep 17, 2020

    Healthy Volunteers Trial in Dallas (Fedratinib, Rifampin, Efavirenz)

    Completed
    • Healthy Volunteers
    • Fedratinib
    • +2 more
    • Dallas, Texas
      Covance Clinical Research Unit Inc - Dallas
    Aug 19, 2020

    Healthy Volunteers Trial in Austin (Fedratinib, Digoxin, Rosuvastatin)

    Completed
    • Healthy Volunteers
    • Fedratinib
    • +3 more
    • Austin, Texas
      PPD Phase 1 Clinic
    May 20, 2020

    Myelofibrosis Trial in Gilbert, Houston (APG-1252, Ruxolitinib)

    Withdrawn
    • Myelofibrosis
    • Gilbert, Arizona
    • +1 more
    Jul 8, 2022

    Myelofibrosis Trial in Worldwide (Selinexor, Physician's Choice Treatment)

    Recruiting
    • Myelofibrosis
    • Los Angeles, California
    • +41 more
    Jan 30, 2023

    Myelofibrosis Trial in Houston (CK0804)

    Not yet recruiting
    • Myelofibrosis
    • Houston, Texas
      The University of Texas MD Anderson Cancer Center
    Jun 28, 2022

    COVID, Corona Virus Infection, Viral Pneumonia Trial in Denmark (Convalescent anti-SARS-CoV-2 plasma, Infusion )

    Terminated
    • COVID
    • +2 more
    • Convalescent anti-SARS-CoV-2 plasma
    • Infusion placebo
    • Aalborg, Denmark
    • +11 more
    Aug 2, 2022

    Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis Trial in Worldwide

    Recruiting
    • Primary Myelofibrosis
    • +2 more
    • Birmingham, Alabama
    • +151 more
    Aug 22, 2022

    Myeloproliferative Tumor (MPN), Myelofibrosis,MF Trial in Chengdu (flonoltinib 25mg, flonoltinib 50mg, flonoltinib 100mg)

    Recruiting
    • Myeloproliferative Neoplasm (MPN)
    • Myelofibrosis,MF
    • flonoltinib 25mg
    • +5 more
    • Chengdu, Sichuan, China
      West China Hospital Sichuan University
    Mar 9, 2022

    Myeloproliferative Tumor (MPN), Myelofibrosis,MF Trial (flonoltinib 25mg, flonoltinib 50mg, flonoltinib 100mg)

    Not yet recruiting
    • Myeloproliferative Neoplasm (MPN)
    • Myelofibrosis,MF
    • flonoltinib 25mg
    • +5 more
    • (no location specified)
    Nov 2, 2021